Somatic mutations of DYNC1H1 have been detected in several cancers, including intraductal papillary mucinous neoplasm, pancreatic neuroendocrine neoplasm, and glioblastoma multiforme.26, 27. This evidence concerns the gene DYNC1H1 and pancreatic intraductal papillary-mucinous neoplasm.